Search filters

List of works by Karl Andersson

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

scientific article published on May 2006

Automated, high-resolution cellular retention and uptake studies in vitro.

scientific article published on 18 April 2006

Avoiding false negative results in specificity analysis of protein-protein interactions

scientific article published on January 1, 2011

Characterization of 111In and 177Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay.

scientific article

Circumventing the requirement of binding saturation for receptor quantification using interaction kinetic extrapolation

scientific article published on September 1, 2011

Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context

scientific article (publication date: 31 January 2011)

Deciphering complex protein interaction kinetics using Interaction Map.

scientific article published on 9 October 2012

Detecting ligand interactions with G protein-coupled receptors in real-time on living cells.

scientific article

Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.

scientific article published on 29 July 2014

Development of a rapid low cost fluorescent biosensor for the detection of food contaminants

scientific article published on 16 August 2012

Evaluation of backbone-cyclized HER2-binding 2-helix affibody molecule for in vivo molecular imaging.

scientific article published on 26 January 2013

Evaluation of real-time immunohistochemistry and interaction map as an alternative objective assessment of HER2 expression in human breast cancer tissue.

scientific article published on December 2013

Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGF

scientific article (publication date: 2011)

Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2.

scientific article

Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design

scientific article

Kinetic determinations of molecular interactions using Biacore--minimum data requirements for efficient experimental design

scientific article

Label-free kinetic binding data as a decisive element in drug discovery.

scientific article

Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area.

scientific article

Methods for radiolabelling of monoclonal antibodies

scientific article published on 01 January 2014

Protein interactions with HER-family receptors can have different characteristics depending on the hosting cell line

scientific article

QSAR studies applied to the prediction of antigen-antibody interaction kinetics as measured by BIACORE.

scientific article published in May 2002

Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.

scientific article published on March 2007

Real-time viability assay based on 51Cr retention in adherent cells.

scientific article

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

scientific article

The influence of Bz-DOTA and CHX-A''-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for (114m)In-mediated targeting therapy.

scientific article

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B—a prerequisite for clinical development

scientific article published on November 10, 2011

[(177)Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells.

scientific article published on 29 September 2005